Ceribell (CBLL) Share-based Compensation (2023 - 2026)
Ceribell's (CBLL) quarterly Share-based Compensation came in at $3.7 million in Q1 2026, up 58.56% YoY from $2.3 million in Q1 2025, and up 10.84% on a QoQ basis from $3.4 million in Q4 2025.
Ceribell (CBLL) Share-based Compensation (2023 - 2026) Analysis & Trends
Ceribell (CBLL) has 4 years of Share-based Compensation data on file, last reported at $3.7 million in Q1 2026.
- Quarterly Share-based Compensation rose 58.56% year-over-year to $3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.6 million (up 44.15% YoY) and the FY2025 annual result came in at $12.2 million, up 125.89% from the prior year.
- Share-based Compensation climbed to $3.7 million in Q1 2026, from $3.4 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $4.6 million in Q4 2024 to a low of $637000.0 in Q3 2023.
- A 4-year average of $2.3 million and a median of $2.3 million in 2025 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2024 — Share-based Compensation jumped 521.88% — and 2025, when it fell 27.5%.
- Tracing CBLL's Share-based Compensation over 4 years: stood at $745000.0 in 2023, then jumped by 521.88% to $4.6 million in 2024, then slipped by 27.5% to $3.4 million in 2025, then gained by 10.84% to $3.7 million in 2026.
- The last three Share-based Compensation figures came in at $3.7 million (Q1 2026), $3.4 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Ceribell | 923.42 Mn | 794.16 Mn | 25.94 Mn | 6.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.00 Mn |
| Jun 30, 2026 | 6.00 Mn |
| Mar 31, 2026 | 3.72 Mn |
| Mar 31, 2026 | 3.72 Mn |
| Dec 31, 2025 | 3.36 Mn |
| Dec 31, 2025 | 3.36 Mn |
| Sep 30, 2025 | 3.35 Mn |
| Sep 30, 2025 | 3.35 Mn |
| Jun 30, 2025 | 3.17 Mn |
| Jun 30, 2025 | 3.17 Mn |
| Mar 31, 2025 | 2.35 Mn |
| Mar 31, 2025 | 2.35 Mn |
| Dec 31, 2024 | 4.63 Mn |
| Dec 31, 2024 | 4.63 Mn |
| Sep 30, 2024 | 1.38 Mn |
| Sep 30, 2024 | 1.38 Mn |
| Jun 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | 1.08 Mn |
| Mar 31, 2024 | 757,000.00 |
| Mar 31, 2024 | 757,000.00 |